COMMUNIQUÉS West-GlobeNewswire

MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
28/05/2026
First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from all cause pneumonia meeting Global ARDS criteria Landmark advances a first-in-class immune [...]
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
28/05/2026
NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a clinical [...]
Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor
28/05/2026
CLEVELAND, OHIO, May 28, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance
28/05/2026
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers Watch the “What This Means” video here TAMPA, Fla. and LONDON, May 28, 2026 (GLOBE NEWSWIRE [...]
MMI Earns Gold Edison Award for Symani®, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
28/05/2026
Symani honored for advancing lymphatic microsurgery – from treating lymphedema to enabling exploration of new disease pathways JACKSONVILLE, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a [...]
Serotonin Centers Opens in Lake Nona, Expanding Physician-Led Longevity Care into One of the Nation’s Leading Health Innovation Communities
28/05/2026
New Location Aligns with Growing Demand for Data-Driven Wellness, Hormone Optimization and Advanced Recovery Therapies ORLANDO, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science- [...]
ProMIS Neurosciences to Participate in Upcoming Conferences in June
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery
28/05/2026
The new AbNano® library enables VHH discovery against complex NK-cell-associated targets for engineered cell platforms and translational research BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences today [...]
Pharming Group announces results of 2026 Annual General Meeting of Shareholders
28/05/2026
Leiden, the Netherlands, May 28, 2026: Pharming Group (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced that shareholders approved all proposals presented at its Annual General [...]
RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation
28/05/2026
Company’s SNMMI week activities highlight scientific progress and two decades of advancing precision nuclear medicine for patients with hard-to-treat cancers HOUSTON, May 28, 2026 (GLOBE NEWSWIRE) -- RadioMedix, Inc., a [...]
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026
28/05/2026
“Best of EASL” oral presentation highlights meaningful reductions in triglycerides, cholesterol, and blood pressure, along with improvements in key metabolic risk factors PERFORMA Phase 3 trial to further evaluate the [...]
H1 Receives $40M Investment in Round Led by CVS Health Ventures
28/05/2026
H1 helps healthcare players transform operations with AI NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- H1 recently received a $40M investment in a round led by CVS Health Ventures , the venture capital investment platform [...]
Clue Becomes the First Insurance-Covered Period and Menstrual Cycle Tracker in the World
28/05/2026
BERLIN, May 28, 2026 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker, today announced a partnership with Süddeutsche Krankenversicherung a. G. (SDK), one of Germany’s leading private health insurers [...]
Valneva annonce sa participation à des conférences investisseurs aux États-Unis et en Europe
28/05/2026
Lyon (France), le 28 mai 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante participeront, en juin 2026, à [...]
Valneva to Participate at U.S. and European Investor Conferences in June
28/05/2026
Lyon (France), May 28, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor [...]
Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program
28/05/2026
XanaMIA randomized, pivotal trial of oral Xanamem 10 mg fully enrolled and remains on track for topline final results in November 2026 SYDNEY, May 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today [...]
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
28/05/2026
SYDNEY, AUSTRALIA, May 28, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune diseases, today announced [...]
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
28/05/2026
SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion of enrollment in the randomized WATER IV [...]
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
28/05/2026
Submission Anticipated in Q4 2026 SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and [...]

Pages